DK1017403T3 - Anvendelse af zinkhyaluronat mod peptisk ulcer - Google Patents

Anvendelse af zinkhyaluronat mod peptisk ulcer

Info

Publication number
DK1017403T3
DK1017403T3 DK98920684T DK98920684T DK1017403T3 DK 1017403 T3 DK1017403 T3 DK 1017403T3 DK 98920684 T DK98920684 T DK 98920684T DK 98920684 T DK98920684 T DK 98920684T DK 1017403 T3 DK1017403 T3 DK 1017403T3
Authority
DK
Denmark
Prior art keywords
peptic ulcer
zinc hyaluronate
against peptic
hyaluronate against
zinc
Prior art date
Application number
DK98920684T
Other languages
Danish (da)
English (en)
Inventor
Laizlo Szporny
Jainos Illes
Judit Matuz
Erzsebet Neszmelyi
Gaborne Forrai
Bela Stefko
Katalin Saghy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK1017403T3 publication Critical patent/DK1017403T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98920684T 1997-04-29 1998-04-28 Anvendelse af zinkhyaluronat mod peptisk ulcer DK1017403T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Publications (1)

Publication Number Publication Date
DK1017403T3 true DK1017403T3 (da) 2006-07-31

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98920684T DK1017403T3 (da) 1997-04-29 1998-04-28 Anvendelse af zinkhyaluronat mod peptisk ulcer

Country Status (27)

Country Link
US (1) US6656921B1 (zh)
EP (1) EP1017403B1 (zh)
JP (1) JP2001522361A (zh)
KR (1) KR100572190B1 (zh)
CN (1) CN1126548C (zh)
AT (1) ATE320814T1 (zh)
BG (1) BG64458B1 (zh)
BR (1) BR9809354A (zh)
CA (1) CA2286756C (zh)
CZ (1) CZ297317B6 (zh)
DE (1) DE69833937T2 (zh)
DK (1) DK1017403T3 (zh)
EA (1) EA002134B1 (zh)
EE (1) EE04953B1 (zh)
ES (1) ES2259813T3 (zh)
HK (1) HK1025250A1 (zh)
HU (1) HU225991B1 (zh)
IL (1) IL132214A0 (zh)
NO (1) NO328313B1 (zh)
NZ (1) NZ500978A (zh)
PL (1) PL189526B1 (zh)
PT (1) PT1017403E (zh)
SK (1) SK284864B6 (zh)
TW (1) TW501927B (zh)
UA (1) UA62964C2 (zh)
WO (1) WO1998048815A1 (zh)
ZA (1) ZA983626B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
AU2006287321B2 (en) * 2005-09-09 2011-09-29 Bally Gaming, Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
US20150209384A1 (en) * 2012-03-01 2015-07-30 Kewpie Corporation Oral preparation for promoting expression of tgf-beta, oral preparation for inhibiting production of pain-mediating substance, and oral preparation for preventing edema
JPWO2015076294A1 (ja) * 2013-11-22 2017-03-16 キユーピー株式会社 薬剤の副作用である胃潰瘍の発症抑制方法、および胃潰瘍発症が抑制された経口薬剤組成物ならびにその製造方法
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
EP0259485A4 (en) * 1986-03-14 1988-07-29 Bio Technology General Corp HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
WO1998048815A1 (en) 1998-11-05
DE69833937D1 (de) 2006-05-11
IL132214A0 (en) 2001-03-19
ZA983626B (en) 1998-11-05
EP1017403A1 (en) 2000-07-12
ATE320814T1 (de) 2006-04-15
HU9700826D0 (en) 1997-06-30
KR20010020413A (ko) 2001-03-15
NO328313B1 (no) 2010-01-25
BG103822A (en) 2000-04-28
TW501927B (en) 2002-09-11
NO995229L (no) 1999-12-22
CA2286756C (en) 2008-02-19
NO995229D0 (no) 1999-10-26
SK146899A3 (en) 2000-06-12
BR9809354A (pt) 2000-07-04
PL189526B1 (pl) 2005-08-31
HU225991B1 (en) 2008-02-28
NZ500978A (en) 2001-05-25
CN1254285A (zh) 2000-05-24
EE04953B1 (et) 2008-02-15
CZ297317B6 (cs) 2006-11-15
HK1025250A1 (en) 2000-11-10
EE9900470A (et) 2000-06-15
DE69833937T2 (de) 2007-06-06
ES2259813T3 (es) 2006-10-16
JP2001522361A (ja) 2001-11-13
CN1126548C (zh) 2003-11-05
CA2286756A1 (en) 1998-11-05
UA62964C2 (en) 2004-01-15
EA199900983A1 (ru) 2000-08-28
KR100572190B1 (ko) 2006-04-18
EA002134B1 (ru) 2001-12-24
PT1017403E (pt) 2006-07-31
CZ382799A3 (cs) 2000-03-15
BG64458B1 (bg) 2005-03-31
EP1017403B1 (en) 2006-03-22
PL336482A1 (en) 2000-06-19
SK284864B6 (sk) 2006-01-05
US6656921B1 (en) 2003-12-02
HUP9700826A1 (hu) 1998-12-28

Similar Documents

Publication Publication Date Title
DK1017403T3 (da) Anvendelse af zinkhyaluronat mod peptisk ulcer
NZ287335A (en) Copolymer-1 composition substantially free of species of copolymer -1 with a mw of from 4 kda to 8 kda, in particular 6.25 kda to 8.4 kda
DK0948357T3 (da) Anvendelse af aminoalkoholer med lav molekylevægt i oftalmiske sammensætninger
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
HK1015269A1 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
SE9802208D0 (sv) Novel compounds
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
EP1155677A3 (en) Methods and compositions for inhibiting free radical polymerization in skin and hair
SE9802209D0 (sv) Novel compounds
EE200200187A (et) Uued fluoroalküülasendatud tsüklotrisiloksaanid, nende kasutamine uute polümeeride valmistamiseks ja uued polümeerid
TR200002939T2 (tr) Paroksetin maleat
GB9505082D0 (en) Medicament
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
FR2787329B1 (fr) Nouvelle application therapeutique des heparines de bas poids moleculaire
TR199901664T2 (xx) Protez di�lerin i�lemden ge�irilmesi i�in bir y�ntem.